Work

Can multiplexing Immunohistochemistry for PD-L1, CD68, and CD3 improve scoring for “Keytruda®” Indication?

Year: 2024

Type: conference-abstract

Source: American Journal of Clinical Pathology

DOI: 10.1093/ajcp/aqae129.212

Authors: S Melvin, M Nam

Institution: Inova Fairfax Hospital

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403416974

Cites:

Cited by:

Related to: 10